Features of Pre-Pregnancy Seizure Control Medication


- The group that received counseling had a significantly lower average frequency of seizures occurring in the month before pregnancy (0.67 seizures/month) than the group that did not receive counseling (1.48 seizures/month), with f=11.86 ANOVA test; p=0.001.

- The rate of patients without seizures for at least 1 year in group 1 (62.8%) was higher than in the group not counseled (20.37%) with RR = 2.62; CI 95% = 1.65-4.17; p = 0.001.

Table 3.4. Characteristics of seizure control medication use before pregnancy



Variable

Group 1


n=43

Group 2


n=54

Total


n=97


P

OR


(95% CI)

RR


(95% CI)

Medication


-Monotherapy


- Multi-therapy


-Are not


34


09


00


33


17


04


67


26


04


0.36


1.95


(0.76-4.9)


1.46


(0.82-2.6)

Use valproate


- Are not

- Have


36


7


26


24


62


31


0.001


4.75


(1.78-12.67)


2.57


(1.3-5.1)

Treatment compliance


- Have


- Are not


38


5


31


19


69


24


0.004


4.65


(1.56-13.89)


1.76


(1.26-2.46)

Valproate dose (mg/day)

Dose ≤ 700 mg/day Over 700 mg/day

514.3


±37.79


7


0

895.8


±254.49


6


18

809, 7


±276.11


13


18


P=0.001

Maybe you are interested!

Features of Pre-Pregnancy Seizure Control Medication


Comment:


- There were 04 patients who did not use anti-epileptic drugs before pregnancy, all in group 2.

- Compared with the group of patients who did not receive counseling, the group that received counseling had a 1.76-fold higher rate of treatment adherence (RR=1.76; CI 95%=1.26-2.46; p=0.0004), a 2.57-fold higher rate of not using valproate (RR=2.57; CI 95%=1.3-5.1; p=0.001), and a lower valproate dose of 514.3 mg/day (f= 15.27; ANOVA test; p=0.001).

3.1.1.3. Clinical characteristics of epileptic patients during pregnancy

A. Characteristics of seizure activity during pregnancy

Table 3.5. Clinical characteristics of seizures in pregnancy



Type of seizure

Group 1

n=43

Group 2

n=54

Total

n=97


p

Generalized epilepsy

29(67.4%)

27(50%)

56(57.7%)


0.137

Partial onset seizures:

There is totalization

Have cognitive impairment

No disturbance of consciousness

14(32.6%)

8

2

4

27(50%)

12

8

7

41(42.3%)

20

10

11


Comment:

The rate of patients with generalized seizures was 57.7%, partial seizures accounted for 42.3%, of which the rate of severe tonic-clonic seizures was 78.35%. There was no statistically significant difference between the two groups in the rate of seizure type (p=0.137).

Table 3.6. Characteristics of the frequency of seizures during pregnancy



Frequency of seizures during pregnancy

Group 1

n=43

Group 2

n=54

Total(%)

n=97

No attack

24

10

34(35.05)

Less than 2 attacks/month

4

14

18(18.55)

2 attacks/month

6

12

18(18.55)

3-4 attacks/month

8

13

21(21.65)


More than 1 attack/week

1

5

6(6.19)


Comment:

- No seizures during pregnancy 35.05%, 1-4 seizures/month 58.76%, more than 1 seizure/week 6.19%.

Table 3.7. Characteristics of seizure activity in pregnancy



Research variables

Group 1


n=43

Group 2


n=54

Total


n=97

No seizures during pregnancy

23(53.5%)

10(18.5%)

33(34.02%)

Average number of seizures/month during pregnancy

1.05±1.31

2.09±1.68

1.63±1.32

Seizure frequency/month during pregnancy Less than 2 seizures

Minimum 2 attacks


28


15


24


30


52


45

Seizure frequency


- Increase


- No change


- Reduce


9(20.9%)


29(67.4%)


5 (11.6%)


28(51.9%)


19(35.2%)


7(12.9%)


37(38.1%)


48(49.5%)


12(11.4%)

Increased seizures during pregnancy:


- Recurrent seizures


- Increased frequency of seizures

9/43


5


4

28/54


6


22

37/97


11


26


Comment:

- The rate of patients with increased seizures during pregnancy was 38.1%, including recurrent seizures (11.34%) and seizures with increased frequency of activity (28.8%).


- The rate of constant seizures during pregnancy was 49.5%, no seizures during pregnancy was 34.02% and only 11.4% had reduced seizure activity during pregnancy.

- The average seizure frequency of patients in the study was 1.63 ± 1,601 seizures/month (min=0 seizures, max=6 seizures/month).

Table 3.8. Comparison of epileptic activity during pregnancy



Research variables

Group 1


n=43

Group 2


n=54

OR


(95% CI)

RR


(95% CI)


p

Partial epilepsy

Are not

27

29

2.07


(0.9-4.6)

1.5


(0.92-2.5)


0.1

Have

14

23

Tonic-clonic seizures

Have

37

39

2.4


(0.8-6.8)

1.4


(0.98-1.9)


0.137

Are not

6

15

Seizures in pregnancy

Are not

23

10

5.1


(2.03-12.6 )

2.2


(1.2-4.3)


0.004

Have

20

44

Increased seizures

Are not

34

26

4.1


(1.6-10.1)

2.3


(1.5-3.4)


0.003

Have

9

28


Frequency of attacks/month during pregnancy

Less than 2 attacks


28


24


2.3


(1.02-5.3)

1.6


(0.99-2.6)


0.065

Minimum 2 attacks


15


30


Average number of attacks/month

1.05±1.31


2.09±1.68


P= 0.001


Comment:

Compared with the uncounseled group, the counseled group had a 2.2-fold higher rate of patients with no seizures during pregnancy (RR=2.2, CI 95%=1.2-4.3, p=0.004); no increased seizures (RR=2.3, CI 95%=1.5-3.4, p=0.003); and a 1.6-fold higher rate of patients with a frequency of less than 2 seizures/month (RR=1.6; CI 95%=0.99-2.6;


p=0.065) as well as the mean number of seizures was 1.04 lower/month (f=12.43 ANOVA test, p=0.001).

Table 3.9. Seizure activity levels during pregnancy



Type of seizure


Increase

No increase


Total

Unchanged

Reduce

Generalized seizures

15

33

8

56

Partial seizures with generalization

11

9

0

20

Partial seizures with cognitive impairment

5

3

2

10

Partial seizure without impaired consciousness

6

2

3

11

Total

37

47

13

97

Comment:

- The rate of patients with increased seizure activity during pregnancy of partial epilepsy is more than 50% (55% with partial seizures with generalization, 50% with partial seizures with cognitive impairment and 54.5% with partial seizures without impaired consciousness).

- The rate of patients with increased seizure activity during pregnancy in generalized epilepsy is only 26.79%.

Table 3.10. Seizure activity according to clinical seizure classification



Variable

General condition


n=56

Local Condition


n=41


p


RR(95%CI)


OR (95% CI)

Seizure 1 year

Have

31

28


0.197

1

1

Are not

25

13

1.25 (0.9-1.7)

1.74(0.75-4.03)

Pregnancy seizures

Have

33

31


0.087

1

1

Are not

23

10

1.4 (0.98-1.9)

2.2(0.89-5.3)

Intensification

Have

15

22


0.007

1

1

Are not

41

19

1.7(1.1-2.6)

3.2(1.4-7.4)

Comment


- The rate of patients without increased seizures during pregnancy in generalized epilepsy was 1.7 times higher than in partial epilepsy (RR=1.68; CI 95%=1.1-2.7; p=0.007), and the rate of patients without seizures during pregnancy was 1.4 times higher (RR=1.4; CI 95%=0.98-1.89, p=0.087).

B. Characteristics of drug use in epilepsy patients during pregnancy Table 3.11. Characteristics of drug use in epilepsy patients during pregnancy


Variable

Group 1


n=43

Group 2


n=54

Total


n=97

Monotherapy:


- Levetiracetam


- Lamotrigine


- Valproate


- Carbamazepine


- Gardenal, phenytoin Multi-therapy:

- Contains levetiracetam


- Contains valproate


- Contains topiramate


- Contains carbamazepines


- Contains gardenal, phenytoin

32(74.1%)


26


2


2


2


0


11 (25.9%)


10


5


1


2


4

23(42.6%)


14


0


4


2


3


31 (57.4%)


23


16


0


8


12

55(56.7%)


40


2


6


4


3


42(43.3%)


33


21


1


10


16

Use valproate

7(16.3%)

20(37%)

27(27.8%)

Can I use levetiracetam?

36(83.7%)

37(68.5%)

73(75.3%)


Comment:

- The proportion of patients using monotherapy was 56.7%. The proportion of patients using levetiracetam was 75.3%, and the proportion using valproate during pregnancy was 27.8%.


Table 3.12. Comparison of antiepileptic drug use during pregnancy between two groups of patients

Variable

Group 1


n=43

Group 2


n=54

OR


(95% CI)

RR


(95% CI)

p


Monotherapy

Have

32

23

3.9


(1.6-9.4)

2.2


(1.3-3.9)

0.002

Are not

11

31

Use valproate

Are not

36

34

3.02


(1.2-8.1)

1.98


(1.01-3.9)

0.039

Have

7

20

Use levetiracetam

Have

36

37

2.4


(0.88-6.4)

1.7


(0.87-3.2)

0.101

Are not

7

17


Adjust medication

Are not

31

16

6.1


(2.5-14.8)

2.7


(1.6-4.7)

0.008

Have

12

38

Treatment compliance

Have

39

33

6.2


(1.9-19.9)

3.4


(1.3-8.5)

0.001

Are not

4

21

Additional


folic acid

Have

39

46

2.6


(0.48-5.1)

1.2


(0.79-1.9)

0.54

Are not

4

8


Comment:

The counseled group had a 2.2-fold higher rate of monotherapy use (RR=2.2; CI 95%=1.3-3.9; p=0.002), a 1.98-fold higher rate of not using valproate (RR=1.98; CI 95%=1.01-3.9; p=0.039), a 2.7-fold higher rate of not needing medication adjustment (RR=2.7; CI 95%=1.6-4.7; p=0.008), and a 3.4-fold higher rate of treatment adherence (RR=3.4; CI 95%=1.8-8.5; p=0.001) compared with the uncounseled group.


C. Characteristics of pregnancy outcomes in epileptic patients

Table 3.13. Clinical characteristics of mother and child during labor



Variable

Group 1


n=43

Group 2


n=54

Total


n=97


p

Average birth weight (kg)

62.5±4.39

61.9±4.03

62.2±4.19

0.51

Average BMI of patients at birth

25.5±1.58

25.4±1.56

25.44±1.56

0.74

Average weight gain during pregnancy

11.7±1.81

11.04±1.86

11.4±1.86

0.084

Average gestational age at birth (weeks)

38.6±1.67

37.9±1.56

38.3±1.63

0.07

Birth weight (kg)

3.11±0.33

2.96±0.38

3.03±0.36

0.047


Comment: The average birth weight of children in the group of patients who received counseling was 0.16 kg higher than that of the group whose mothers did not receive counseling (t=2.005, T-test; p=0.047)

Table 3.14. Maternal and fetal events during pregnancy


Event

Group 1 (n=43)

Group 2 (n=54)

Total (n=97)

Active abortion

0

6

6

Miscarriage

0

1

1

Premature birth

1

5

6

labor spasms

1

3

4

Children with congenital abnormalities

0

1

1

Total maternal and child events

2

16

18


Comments: The number of events occurred mostly in the group that did not receive counseling (16/18 cases, accounting for 88.9%), the most common events were premature birth (6/18 cases, accounting for 33.3%) and abortion (6/18 cases, accounting for 33.3%).

Comment


Agree Privacy Policy *